AtriCure, Inc. (NASDAQ:ATRC)

CAPS Rating: 5 out of 5

The Company develops, manufactures and sells innovative surgical devices designed to create precise lesions, or scars, in cardiac and soft tissues.

ATRC News and Commentary

Caps

How do you think ATRC will perform against the market?

Add Stock to CAPS Watchlist

All Players

55 Outperform
6 Underperform
 

All-Star Players

9 Outperform
1 Underperform
 

Wall Street

6 Outperform
0 Underperform
 

Top ATRC Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

pennysplants (99.18)
Submitted June 29, 2010

Sometimes, you just take a small position in a long shot ... and ride it out. I think AtriCure may have turned the corner. Still a long shot ... but no longer a crap shoot.

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

ATRC VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from players about ATRC.

Recs

0
Member Avatar Turtlebale (49.33) Submitted: 8/26/2016 2:37:46 PM : Outperform Start Price: $14.70 ATRC Score: +3.86

growing markets

Recs

0
Member Avatar TripleTheMarket (< 20) Submitted: 6/2/2011 1:05:41 PM : Outperform Start Price: $14.45 ATRC Score: -71.06

Momentum!

Recs

0
Member Avatar dstnewman (94.23) Submitted: 2/23/2008 3:23:31 PM : Outperform Start Price: $11.95 ATRC Score: -47.07

Strongly considering adding this to my real portfolio when I get a little more cash to invest.

New company just came public back in 2006. The have had consistant growth ever since. One of the biggest attractions that I have to the company is the fact that a large portion of it's income is from procedures that are not officially FDA approved. It is working towards approval, at which point it can start marketing it specifically for that cause. Margins are very good and Y-O-Y growth looks quite interesting. It is still a couple years from being profitable though, which makes it very speculative, but it has multiple FDA trials that are scheduled to be completed this year (08), which means that there are a LOT of catalysts for growth.

Leaderboard

Find the members with the highest scoring picks in ATRC.

Score Leader

Buckless1120

Buckless1120 (< 20) Score: +181.75

The Score Leader is the player with the highest score across all their picks in ATRC.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
Buckless1120 < 20 11/3/2008 Outperform 1Y $4.00 +357.50% +174.41% +183.09 0 Comment
OptimumTime < 20 12/23/2011 Underperform 5Y $11.64 +57.22% +106.45% +49.23 0 Comment
bashstocks 33.18 3/4/2013 Outperform 1Y $8.50 +114.71% +71.62% +43.08 0 Comment
pkhann1 < 20 2/14/2013 Outperform 1Y $8.54 +113.70% +71.06% +42.64 0 Comment
perovskite 48.67 2/8/2007 Underperform 5Y $12.22 +49.75% +90.88% +41.13 0 Comment
n2camo < 20 8/14/2013 Outperform 3M $9.39 +94.36% +53.63% +40.72 0 Comment
invest4321 25.68 8/10/2010 Outperform 5Y $6.80 +169.12% +132.54% +36.58 0 Comment
looktroyson 33.41 6/25/2013 Outperform 5Y $9.25 +97.30% +64.61% +32.69 0 Comment
RafaelToday < 20 8/1/2014 Underperform 5Y $16.49 +10.67% +35.26% +24.59 0 Comment
macsaint 89.71 2/26/2007 Underperform 5Y $10.70 +71.03% +89.51% +18.48 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackCanaccord 41.06 12/20/2013 Outperform NS $16.10 +13.35% +44.16% -30.81 0 Comment
TrackKaufmanBros 93.37 9/22/2011 Outperform NS $9.76 +87.50% +129.91% -42.41 0 Comment
TrackJMP 84.89 9/8/2011 Outperform NS $10.46 -28.30% +15.87% -44.17 8/3/2012 @ $7.50 0 Comment
TrackMorganKeeg 73.08 8/24/2011 Outperform NS $10.99 +66.52% +124.09% -57.57 0 Comment
TrackBMOCapital < 20 4/23/2008 Outperform NS $12.00 +52.50% +96.02% -43.52 0 Comment
TrackRodmanRen < 20 2/28/2008 Outperform NS $12.16 +50.49% +97.72% -47.23 0 Comment
TrackBarrington 90.79 12/19/2007 Outperform NS $12.16 +50.49% +86.92% -36.42 0 Comment
TrackStanfordRes < 20 10/9/2007 Outperform NS $10.79 -20.02% -11.34% -8.68 4/17/2012 @ $8.63 0 Comment
TrackAGEdwards < 20 2/16/2007 Outperform NS $12.18 -19.13% +5.90% -25.03 6/1/2007 @ $9.85 0 Comment
TrackRothCapital 72.74 2/2/2007 Outperform NS $10.74 -63.22% -32.72% -30.51 11/3/2008 @ $3.95 0 Comment
TrackPiperJaff 85.13 8/9/2006 Outperform NS $6.60 -47.58% -27.85% -19.73 7/1/2009 @ $3.46 0 Comment

Featured Broker Partners